Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits

Figure 2

RNA integrity of samples. RNA derived from (A) the drug sensitive-recipient cell (CEM), (B) drug-resistant VLB100 cells, (C) their isolated MPs (VLBMP) and (D) the drug sensitive-recipient cells after MP transfer (CEM + VLBMP) was analysed using Agilent RNA 6000 Nano kit by Agilent 2100 Bioanalyzer. The RIN value of the samples ranged between 6.2-9.2. Data is representative of a typical experiment

Back to article page

Molecular Cancer

ISSN: 1476-4598